1978
DOI: 10.3109/00016487809124755
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of the Endocochlear Potential by the New “Loop” Diuretic, Bumetanide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0
1

Year Published

1996
1996
2018
2018

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 37 publications
(6 citation statements)
references
References 24 publications
0
5
0
1
Order By: Relevance
“…Conversely, SLC12A2 deficiency, as discussed above, leads to deafness without leading to overt renal salt wasting (43,57). Importantly, both SLC12A1 and SLC12A2 are inhibited by loop diuretics such as furosemide, and thus inhibition of Na ϩ -2Cl Ϫ -K ϩ cotransport in the inner ear during excessive doses of loop diuretics leads to an accumulation of K ϩ in the intrastrial space, which abolishes the endocochlear potential (129) and leads to hearing loss (81,96,322). Much lower doses are sufficient to inhibit luminal SLC12A1 in the thick ascending limb, since the drug accumulates in the tubular fluid as a consequence of efficient secretion into proximal tubular fluid and fluid reabsorption along the tubule.…”
Section: Functions Of Inner Ear Channels and Transporters In Renal Epmentioning
confidence: 96%
See 2 more Smart Citations
“…Conversely, SLC12A2 deficiency, as discussed above, leads to deafness without leading to overt renal salt wasting (43,57). Importantly, both SLC12A1 and SLC12A2 are inhibited by loop diuretics such as furosemide, and thus inhibition of Na ϩ -2Cl Ϫ -K ϩ cotransport in the inner ear during excessive doses of loop diuretics leads to an accumulation of K ϩ in the intrastrial space, which abolishes the endocochlear potential (129) and leads to hearing loss (81,96,322). Much lower doses are sufficient to inhibit luminal SLC12A1 in the thick ascending limb, since the drug accumulates in the tubular fluid as a consequence of efficient secretion into proximal tubular fluid and fluid reabsorption along the tubule.…”
Section: Functions Of Inner Ear Channels and Transporters In Renal Epmentioning
confidence: 96%
“…The Na ϩ /K ϩ -ATPase in strial marginal cells and vestibular dark cells as well as in fibrocytes of the spiral ligament consists of the subunits ATP1A1, ATP1B1, and ATP1B2 (173,230) (Fig. 2D) Inhibition of Na ϩ /K ϩ -ATPase with ouabain inhibits K ϩ secretion and consequently abolishes the endocochlear potential (126,129). Strial marginal cells appear to express gastric K ϩ /H ϩ -ATPase in addition to Na ϩ /K ϩ -ATPase (135,235).…”
Section: K ϩ Cycling In the Inner Earmentioning
confidence: 98%
See 1 more Smart Citation
“…For intravenous injection, a 3 ml solution containing 30 mg/kg bumetanide was made from its stock solution and the control solution and applied to the right jugular vein in 3 min [24] through a catheter.…”
Section: Perilymphatic and Vascular Application Of The Blockersmentioning
confidence: 99%
“…In Übereinstimmung mit dem vorgestellten Modell führt die Gabe von Ouabain, einem Blocker der Na,K-ATPase, oder von Furosemid, einem Blocker des Na + /Cl − /K + -Cotransporters, zum Zusammenbruch des endokochlearen Potentials [9][10][11][12].…”
Section: Introductionunclassified